Butalbital and acetaminophen is supplied in tablet form for oral administration.
Butalbital and Acetaminophen Tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Media Articles Related to Sedapap (Butalbital / Acetaminophen)
Vitamin D deficiency increases risk of chronic headache
Source: Headache / Migraine News From Medical News Today [2017.01.04]
Vitamin D deficiency may increase the risk of chronic headache, according to a new study from the University of Eastern Finland. The findings were published in Scientific Reports.
Source: MedicineNet Acupuncture Specialty [2016.11.30]
Title: Headache Remedies
Category: Diseases and Conditions
Created: 4/12/2016 12:00:00 AM
Last Editorial Review: 11/30/2016 12:00:00 AM
Visits to pediatric emergency departments for headache pain in children are on the rise
Source: Headache / Migraine News From Medical News Today [2016.10.24]
At 1 hospital, rates of emergency department visits and subsequent hospital admission doubled over a 7-year period.
Headaches and Menopause: What's the Connection?
Source: Headache / Migraine News From Medical News Today [2016.09.29]
Headaches are among the symptoms some women report during menopause. Learn more about what causes them, what other symptoms occur, and treatment options.
Tension Headaches: Treatment, Causes, and Symptoms
Source: Headache / Migraine News From Medical News Today [2016.09.21]
Tension headaches, often described as a pressing or tightening pain of mild to moderate intensity, are the most common type of headache.
Published Studies Related to Sedapap (Butalbital / Acetaminophen)
Sumatriptan-Naproxen and Butalbital: A Double-Blind, Placebo-Controlled Crossover Study. [2011.11.21]
Objectives.- The primary objective was to compare the efficacy of a sumatriptan and naproxen combination medication (SumaRT/Nap-85 mg sumatriptan and 500 mg naproxen sodium), a butalbital-containing combination medication (BCM-50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine), and placebo when used to treat moderate to severe migraine headache pain in subjects who used BCMs in the past.
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.
Page last updated: 2017-01-04